Procter & Gamble Company (The) $PG Stock Sold by Commonwealth Financial Services LLC

Commonwealth Financial Services LLC lessened its holdings in Procter & Gamble Company (The) (NYSE:PG) by 34.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,284 shares of the company’s stock after selling 8,405 shares during the quarter. Commonwealth Financial Services LLC’s holdings in Procter & Gamble were worth $2,366,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Procter & Gamble in the second quarter valued at $27,862,105,000. State Street Corp grew its stake in Procter & Gamble by 1.0% in the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company’s stock valued at $14,988,999,000 after buying an additional 965,461 shares in the last quarter. Bank of America Corp DE bought a new stake in Procter & Gamble during the 2nd quarter valued at $3,850,628,000. Bank of New York Mellon Corp bought a new position in shares of Procter & Gamble in the second quarter worth $2,281,505,000. Finally, Dimensional Fund Advisors LP grew its holdings in Procter & Gamble by 2.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock valued at $1,704,182,000 after buying an additional 300,280 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble raised its dividend for the 70th consecutive year, reinforcing its status as a premier income stock and supporting investor confidence in the durability of its cash flows. The Ultimate Dividend Growth Stock to Buy With $100 Right Now
• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and assigned a $166 price target, implying roughly 4.7% upside from the cited share price. The endorsement suggests confidence in PG’s defensive business model and earnings outlook. Benzinga analyst-rating report
• Positive Sentiment: Analysts and financial commentators highlighted PG’s innovation strategy, including brand investment, artificial-intelligence capabilities and productivity initiatives. These efforts could improve market share and revive organic sales growth over the long term. Procter & Gamble’s Innovation Push
• Positive Sentiment: A new Head & Shoulders Scalp Care Collection uses targeted, clinically tested formulations for different scalp-health needs, providing another example of PG’s effort to premiumize and refresh established brands. Why Is Procter & Gamble Refreshing Its Scalp Care Playbook Now?
• Neutral Sentiment: PG’s fiscal first-quarter results are scheduled for October 22. Preview coverage is centered on whether improving product volumes can offset pricing pressure, with investors watching organic sales, margins and management’s outlook closely. Procter & Gamble Earnings Preview
• Negative Sentiment: PG’s dividend yield is less attractive than Nike’s after Nike’s steep share-price decline, which may encourage income investors to compare alternatives. This is a relative-valuation concern rather than a change to PG’s dividend policy. Nike Now Yields More Than Procter & Gamble

Procter & Gamble Stock Up 0.5%

PG traded up $0.75 during trading on Tuesday, reaching $158.44. The stock had a trading volume of 2,439,128 shares, compared to its average volume of 9,665,321. The stock’s 50 day moving average is $147.11 and its two-hundred day moving average is $146.62. The company has a market capitalization of $368.01 billion, a price-to-earnings ratio of 23.94, a P/E/G ratio of 3.96 and a beta of 0.39. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. Procter & Gamble Company has a one year low of $137.62 and a one year high of $167.25.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The company had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.38 billion. During the same quarter in the prior year, the business posted $1.48 EPS. The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.98 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. Procter & Gamble’s payout ratio is currently 65.71%.

Insider Activity

In other news, CAO Matthew W. Janzaruk sold 359 shares of Procter & Gamble stock in a transaction on Monday, August 24th. The shares were sold at an average price of $145.24, for a total transaction of $52,141.16. Following the transaction, the chief accounting officer owned 1,271 shares in the company, valued at $184,600.04. This trade represents a 22.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Andre Schulten sold 3,914 shares of the company’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the completion of the sale, the chief financial officer owned 65,618 shares of the company’s stock, valued at approximately $9,536,920.12. The trade was a 5.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 15,135 shares of company stock valued at $2,189,970. Corporate insiders own 0.23% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Citigroup boosted their target price on Procter & Gamble from $170.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, October 9th. Sanford C. Bernstein reissued a “market perform” rating and issued a $149.00 target price on shares of Procter & Gamble in a research note on Monday, August 24th. Argus lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Evercore upgraded shares of Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target on the stock in a research report on Tuesday, October 6th. Finally, Bank of America reduced their target price on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a report on Friday, July 10th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $162.20.

Procter & Gamble Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.